Regency Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,305
| Closed | -$64.6K | – | 60 |
|
|
2023
Q3 | $64.6K | Sell |
1,305
-1,957
| -60% | -$96.8K | 0.05% | 45 |
|
|
2023
Q2 | $255K | Hold |
3,262
| – | – | 0.22% | 37 |
|
|
2023
Q1 | $296K | Hold |
3,262
| – | – | 0.36% | 28 |
|
|
2022
Q4 | $385K | Buy |
3,262
+1
| +0% | +$118 | 0.44% | 28 |
|
|
2022
Q3 | $592K | Hold |
3,261
| – | – | 0.73% | 27 |
|
|
2022
Q2 | $292K | Buy |
+3,261
| New | +$292K | 0.31% | 32 |
|